Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissues

British Journal of Cancer

Volumn 88, Issue 7, 2003, Pages 1101-1104

  Nakamura, T ^a   Scorilas, A ^b   Stephan, C ^a,c   Yousef, G M ^a,d   Kristiansen, G ^c   Jung, K ^c   Diamandis, E P ^a,d  

^a MOUNT SINAI HOSPITAL   (Canada)

^b INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Macrophage inhibitory factor 1; Prostate cancer; Quantitative RT PCR

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; MACROPHAGE INHIBITORY CYTOKINE 1; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER DIAGNOSIS; DOWN REGULATION; GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATE TUMOR; PROSTATECTOMY; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

AGED; CYTOKINES; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0038076012     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600869     Document Type: Article

References (23)

1. Bieche I, Olivi M, Champeme MH, Vidaud D, Lidereau R, Vidaud M (1998) Novel approach to quantitative polymerase chain reaction using real-time detection: application to the detection of gene amplification in breast cancer. Int J Cancer 78: 661-666
2. Bieche I, Onody P, Laurendeau I, Olivi M, Vidaud D, Lidereau R, Vidaud M (1999) Real-time reverse transcription - PCR assay for future management of ERBB2-based clinical applications. Clin Chem 45: 1148-1156
3. Bilhartz DL, Tindall DJ, Oesterling JE (1991) Prostate-specific antigen and prostatic acid phosphatase: biomolecular and physiologic characteristics. Urology 38: 95-102
4. Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, He XY, He XY, Zhang HP, Donnellan M, Mahler S, Pryor K, Walsh BJ, Nicholson RD, Fairlie WD, Por SB, Robbins JM, Breit SN (1997) MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci USA 94: 11514-11519
5. Bottner M, Suter-Crazzolara C, Schober A, Unsicker K (1999) Expression of a novel member of the TGF-beta superfamily, growth/differentiation factor-15/macrophage-inhibiting cytokine-1 (GDF-15/MIC-1) in adult rat tissues. Cell Tissue Res 297: 103-110
6. Buckhaults P, Rago C, St Croix B, Romans KE, Saha S, Zhang L, Vogelstein B, Kinzler KW (2001) Secreted and cell surface genes expressed in benign and malignant colorectal tumors. Cancer Res 61: 6996-7001
7. Diamandis EP, Yousef GM, Clements J, Ashworth LK, Yoshida S, Egelrud T, Nelson PS, Shiosaka S, Little S, Lilja H, Stenman UH, Rittenhouse HG, Wain H (2000a) New nomenclature for the human tissue kallikrein gene family. Clin Chem 46: 1855-1858
8. Diamandis EP, Yousef GM, Luo LY, Magklara A, Obiezu CV (2000b) The human kallikrein gene family - implications in carcinogenesis. Trends Endocrinol Metab 11: 54-60
9. Hromas R, Hufford M, Sutton J, Xu D, Li Y, Lu L (1997) PLAB, a novel placental bone morphogenetic protein. Biochim Biophys Acta 1354: 40-44
10. Meyer A, Jung K, Lein M, Rudolph B, Schnorr D, Loening SA (1997) Factors influencing the ratio of free to total prostate-specific antigen in serum. Int J Cancer 74: 630-636
11. Meyer-Siegler KL, Bellino MA, Tannenbaum M (2002) Macrophage migration inhibitory factor evaluation compared with prostate specific antigen as a biomarker in patients with prostate carcinoma. Cancer 94: 1149-1156
12. Mitchell ID, Croal BL, Dickie A, Cohen NP, Ross I (2001) A prospective study to evaluate the role of complexed prostate specific antigen and free/total prostate specific antigen ratio for the diagnosis of prostate cancer. J Urol 165: 1549-1553
13. Oesterling JE (1991) Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 145: 907-923
14. Polascik TJ, Oesterling JE, Partin AW (1999) Prostate specific antigen: a decade of discovery - what we have learned and where we are going. J Urol 162: 293-306
15. Rittenhouse HG, Finlay JA, Mikolajczyk SD, Partin AW (1998) Human kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate. Crit Rev Clin Lab Sci 35: 275-368
16. Shariat SF, Shalev M, Menesses-Diaz A, Kim IY, Kattan MW, Wheeler TM, Slawin KM (2001) Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy. J Clin Oncol 19: 2856-2864
17. Stamey TA (2001) Preoperative serum prostate-specific antigen (PSA) below 10 microg/l predicts neither the presence of prostate cancer nor the rate of postoperative PSA failure. Clin Chem 47: 631-634
18. Stephan C, Jung K, Diamandis EP, Rittenhouse HG, Lein M, Loening SA (2002) Prostate-specific antigen, its molecular forms and other kallikrein markers for detection of prostate cancer. Urology 59: 2-8
19. Sullivan Pepe M, Etzioni R, Feng Z, Potter JD, Thompson ML, Thornquist M, Winget M, Yasui Y (2001) Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 93: 1054-1061
20. Thomas R, True LD, Lange PH, Vessella RL (2001) Placental bone morphogenetic protein (PLAB) gene expression in normal, premalignant and malignant human prostate: relation to tumor development and progression. Int J Cancer 93: 47-52
21. Welsh JB, Sapinoso LM, Su AI, Kern SG, Wang-Rodriguez J, Moskaluk CA, Frierson Jr HF, Hampton GM (2001) Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res 61: 5974-5978
22. Wittwer CT, Herrmann MG, Moss AA, Rasmussen RP (1997) Continuous fluorescence monitoring of rapid cycle DNA amplification. Biotechniques 22: 130-138
23. Wong YC, Xie W, Tsao SW (2000) Structural changes and alteration in expression of TGF-beta1 and its receptors in prostatic intraepithelial neoplasia (PIN) in the ventral prostate of noble rats. Prostate 45: 289-298